Call us for quotes at (610) 458-1112 or 
Email us at primbiobiz@primbioresearch.com
PRIMBIO
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Cancer Hotspot Panel
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • COVID-19 RT-PCR TEST
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote
  • Home
  • Company
    • About Us
    • Our Team
    • Publications
    • Careers
  • Technology
    • Illumina NextSeq 2000
    • Ion GeneStudio™ S5 Prime System
    • QuantStudio™ 12K PCR System
  • Research Services
    • RNA-seq
    • Exome Sequencing
    • Gene Panels
    • 16S Metagenomic Sequencing
    • Real-time qPCR
  • Clinical Tests
    • Cancer Hotspot Panel
    • Colorectal Cancer Panel
    • Breast Cancer Therapy Panel
    • COVID-19 RT-PCR TEST
    • UTI QPCR TEST
    • COVID/FLU/RSV RT-PCR TEST
  • Get a Quote

PrimBio UTI QPCR TEST

What is UTI and who should get the tested?
  • A urinary tract infection or UTI occurs when pathogenic (harmful) bacteria/fungus grow above a certain threshold
  • UTIs usually originate in the bladder or another part of the urinary tract.
  • UTIs are responsible for nearly 10 million doctor visits each year in the US.
  • If UTIs do not get properly treated in a timely manner they may result in serious health issues such as kidney failure 
What is a molecular UTI qPCR Test?
  • A molecular UTI test uses quantitative Polymerase Chain Reaction (qPCR), a method that is used to amplify  and quantify the amount of DNA in a sample, to determine if a certain species of a microorganism is present in a urine sample​​

The PrimBio UTI qPCR Test can:
  • Determine the exact bacterial species that is causing the infection in the patient
  • Determine the approximate concentration of bacteria/fungus (CFU/mL) that is in the patient's urine
  • Determine if the patient has bacteria that is resistant to certain antibiotics
  • Provide recommendations to the physician for the most appropriate treatment to treat that specific patient
  • Provide an appropriate treatment regimen in good stewardship which reduces the risk of antibiotic resistance
  • Help discover an alternative treatment plan
​
Molecular Diagnostic 
​Requisition Form
Sample Submission
​Guidelines

© COPYRIGHT 2016. ALL RIGHTS RESERVED.